SCHEMBL20867658

SCHEMBL20867658

COc1cc(OC)c2nc(Cc3ccccc3)cc(C)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.41
PLA2G2A P14555 1/20 0.40
KDR P35968 1/20 0.39
KMT2A Q03164 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20855334 0.75 ALOX5 (0.39)
SCHEMBL20867656 0.75 MAPT (0.50) KMT2ASMN1; SMN2KDM4EGAAMAPT
SCHEMBL28593997 0.73 LMNA (0.61) LTA4HKMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL20855332 0.73 NQO2 (0.42) KMT2ASMN1; SMN2ALDH1A1KDM4EPDE3A
SCHEMBL22196185 0.72 KMT2A (0.44) KMT2ASMN1; SMN2NPC1ALDH1A1KDM4E
SCHEMBL12135962 0.71 PDE5A (0.53) KMT2ASMN1; SMN2ALDH1A1KDM4EPDE3B
SCHEMBL20861714 0.71 NQO2 (0.34) KMT2ASMN1; SMN2GAATDP1CYP1A2
SCHEMBL18029929 0.71 LTA4H (0.57) LTA4HALDH1A1CYP1A2PTPN1CYP3A4
SCHEMBL27769290 0.71 LTA4H (0.49) LTA4HKMT2AALDH1A1POLBMEN1
SCHEMBL20867655 0.70 NQO2 (0.45) KMT2ASMN1; SMN2PDE3BPDE3AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200216430-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2020-07-09 US disclosed
WO-2019060998-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2019-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200216430-A1 CATALYST-FREE AND REDOX-NEUTRAL INNATE TRIFLUOROMETHYLATION AND ALKYLATION OF (HETERO)AROMATICS ENABLED BY LIGHT CYBB, NOX4, NOX3 LTA4H 696/4885PLA2G2A 2795/4885KDR 4117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.